Immediate Impact

74 standout
Sub-graph 1 of 21

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
24 intermediate papers

Works of S.M. Ibrahim being referenced

A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
2009

Author Peers

Author Last Decade Papers Cites
S.M. Ibrahim 389 189 22 138 12 439
Laura E. Moreno-Luna 356 226 23 139 9 456
K Ohnishi 329 147 30 87 11 422
Fumie Kurokawa 331 217 32 93 17 430
Nadine Abouchaleh 425 174 8 138 15 459
Lauranne Piron 319 162 14 147 21 401
Shun‐ichi Ariizumi 370 157 21 230 21 465
Bo Hyun Kim 334 142 55 75 14 422
O Matsui 361 136 16 202 8 479
Taro Takeda 260 80 6 139 13 375
Yoshikazu Nagasaki 335 205 23 113 13 428

All Works

Loading papers...

Rankless by CCL
2026